Antonia A Högnäsbacka (Antonia Högnäsbacka)

Publication Activity (10 Years)

Years Active: 2022-2024
Publications (10 Years): 9

Top Topics

Advanced Non Small Cell Lung Cancer

Tyrosine Kinase

Positron Emission Tomography

Top Venues

Journal of labelled compounds & radiopharmaceuticals

EJNMMI research

Journal of medicinal chemistry

Pharmaceuticals (Basel, Switzerland)

This page only lists publications with an associated author ORCID identifier.

Publications

Antonia A Högnäsbacka, Alex J Poot, Christophe Plisson, Jonas Bergare, David R Bonsall, Stuart P McCluskey, Lisa A Wells, Esther Kooijman, Robert C Schuit, Mariska Verlaan, Wissam Beaino, Guus A M S van Dongen, Danielle J Vugts, Charles S Elmore, Jan Passchier, Albert D Windhorst
Synthesis and preclinical evaluation of [ 11 C]EAI045 as a PET tracer for imaging tumors expressing mutated epidermal growth factor receptor. EJNMMI research 14 (1) (2024)
Antonia A Högnäsbacka, Alex J Poot, Christophe Plisson, Jonas Bergare, David R Bonsall, Stuart P McCluskey, Lisa A Wells, Esther Kooijman, Robert C Schuit, Mariska Verlaan, Wissam Beaino, Guus A M S van Dongen, Danielle J Vugts, Charles S Elmore, Jan Passchier, Albert D Windhorst
Synthesis and preclinical evaluation of [ 11 C]EAI045 as a PET tracer for imaging tumors expressing mutated epidermal growth factor receptor. EJNMMI research 14 (1) (2024)
Antonia A Högnäsbacka, Alex J Poot, Christophe Plisson, Jonas Bergare, David R Bonsall, Stuart P McCluskey, Lisa A Wells, Esther Kooijman, Robert C Schuit, Mariska Verlaan, Wissam Beaino, Guus A M S van Dongen, Danielle J Vugts, Charles S Elmore, Jan Passchier, Albert D Windhorst
Synthesis and preclinical evaluation of [ 11 C]EAI045 as a PET tracer for imaging tumors expressing mutated epidermal growth factor receptor. EJNMMI research 14 (1) (2024)
Miguel A Cortés González, Antonia A Högnäsbacka, Christer Halldin, Magnus Schou
Validation of a good manufacturing practice procedure for the production of [ 11 C]AZD4747, a CNS penetrant KRAS G12c inhibitor. Journal of labelled compounds & radiopharmaceuticals (2023)
Miguel A Cortés González, Antonia A Högnäsbacka, Christer Halldin, Magnus Schou
Validation of a good manufacturing practice procedure for the production of [ 11 C]AZD4747, a CNS penetrant KRAS G12c inhibitor. Journal of labelled compounds & radiopharmaceuticals 67 (6) (2023)
Miguel A Cortés González, Antonia A Högnäsbacka, Christer Halldin, Magnus Schou
Validation of a good manufacturing practice procedure for the production of [ 11 C]AZD4747, a CNS penetrant KRAS G12c inhibitor. Journal of labelled compounds & radiopharmaceuticals 67 (6) (2023)
Antonia A Högnäsbacka, Alex J Poot, Esther Kooijman, Robert C Schuit, Maxime Schreurs, Mariska Verlaan, Wissam Beaino, Guus A M S van Dongen, Danielle J Vugts, Albert D Windhorst
Synthesis and Preclinical Evaluation of [ Methylpiperazine - 11 C]brigatinib as a PET Tracer Targeting Both Mutated Epidermal Growth Factor Receptor and Anaplastic Lymphoma Kinase. Journal of medicinal chemistry (2023)
Antonia A Högnäsbacka, Alex J Poot, Danielle J Vugts, Guus A M S van Dongen, Albert D Windhorst
The Development of Positron Emission Tomography Tracers for In Vivo Targeting the Kinase Domain of the Epidermal Growth Factor Receptor. Pharmaceuticals (Basel, Switzerland) 15 (4) (2022)
Antonia A Högnäsbacka, Miguel A Cortés González, Christer Halldin, Magnus Schou
Simplified and accessible [ 18 F]F-AraG synthesis procedure for preclinical PET. Journal of labelled compounds & radiopharmaceuticals 65 (10-11) (2022)